Pharmaceutical Preparations · CIK 1651308
BeOne Medicines Ltd. develops and commercializes innovative therapies for unmet medical needs
Comparable business profile · signals at a glance
In the last 90 days: 4 sold $567K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Wang LaiPresident, Global Head of R&D | Sell | 756 | $261.00 | $197K |
| Jun 11, 2026 | Wu XiaobinPresident and COO | Sell | 626 | $261.20 | $164K |
| Jun 11, 2026 | Rosenberg AaronChief Financial Officer | Sell | 631 | $257.74 | $163K |
| Jun 11, 2026 | Ball Titus B.Principal Accounting Officer | Sell | 120 | $257.53 | $31K |
| Jun 11, 2026 | Ball Titus B.Principal Accounting Officer | Sell | 49 | $256.39 | $13K |
| Mar 11, 2026 | Lee Chan HenrySVP, General Counsel | Sell | 341 | $300.00 | $102K |
| Feb 4, 2026 | Lee Chan HenrySVP, General Counsel | Sell | 996 | $350.00 | $349K |
| Feb 4, 2026 | Lee Chan HenrySVP, General Counsel | Sell | 664 | $348.79 | $232K |
| Jan 7, 2026 | Lee Chan HenrySVP, General Counsel | Sell | 664 | $331.76 | $220K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 7,470 | $302.74 | $2.3M |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 5,442 | $303.72 | $1.7M |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 2,567 | $301.79 | $775K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 1,973 | $304.36 | $601K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 1,877 | $300.80 | $565K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 1,633 | $303.13 | $495K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 1,512 | $302.31 | $457K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 1,255 | $304.13 | $382K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 600 | $300.98 | $181K |
| Dec 16, 2025 | Oyler JohnChief Executive Officer | Sell | 40 | $305.24 | $12K |
| Dec 15, 2025 | Oyler JohnChief Executive Officer | Sell | 16,318 | $310.48 | $5.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.